European Association for Cancer Research (EACR) - Boehringer Ingelheim Conference: Drugging and Regulating The Mitogen Activated Protein Kinase (MAPK) Pathway

European Association for Cancer Research (EACR) - Boehringer Ingelheim Conference: Drugging and Regulating The Mitogen Activated Protein Kinase (MAPK) pathway is organized by European Association for Cancer Research (EACR) and will be held from Feb 11 - 12, 2025.

Description:
The Mitogen Activated Protein Kinase (MAPK) pathway is one of the most commonly mutated signalling pathways in human cancers. While a range of small molecule inhibitors have been developed to inhibit the upstream and downstream effectors of this pathway, resistance remains a significant challenge.

Topics to be covered:

• Regulation of MAPK signalling
• Drug resistance mechanisms
• Rational combination therapies
• Cross-resistance to immune modulators